Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Nanterre, France Clinical Trials

A listing of Nanterre, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (25) clinical trials

Can Subthalamic Stimulation Using Directional Electrodes Improve Postoperative Management in Parkinson's Disease

This project of further use of health-related data with consent by the participants is a prospective, international project to evaluate the improvement of neuropsychiatric symptoms and the quality of life 12 months after surgery in a large consecutive series of STN-DBS PD patients using novel implantable Neurostimulator Systems (Boston Scientific). …

Phase N/A

7.81 miles

Learn More »

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

The RAISE-XT study is an open-label extension study to evaluate the long-term efficacy, safety, and tolerability of zilucoplan in subjects with gMG who have previously participated in a qualifying Ra Pharmaceuticals sponsored zilucoplan study.

Phase

7.81 miles

Learn More »

Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;

It is a muliticentric, observational, prospective study. This study will be conducted in about 40 geriatric settings in France. The planned duration of the inclusion period is 18 months in each center. The follow-up period starts one year after inclusion with phone contact or unscheduled visit at 3, 6, 9 …

Phase N/A

7.81 miles

Learn More »

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

The purpose of this Phase 2/3 study is to evaluate efficacy and safety of the combination of selinexor and R-GDP (SR-GDP) in patients with RR DLBCL who are not intended to receive hematopoetic stem cell transplantation (HSCT) or chimeric antigen receptor T cell (CAR-T) therapy. The Phase 2 portion of …

Phase

7.81 miles

Learn More »

Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.

Background Gangrenous cholecystitis is the most common complication of acute cholecystitis affecting around 15% (range 2-30%) of patients and it occurs as a result of ischemia with necrosis of the gallbladder wall [1]. It is related to an increased mortality rate (mortality rate ranging between 15 and 50%) compared with …

Phase N/A

8.06 miles

Learn More »